- Author:
Xu ZHANG
1
;
Jianping LI
Author Information
- Publication Type:Case Reports
- MeSH: ABO Blood-Group System; genetics; Alleles; Base Sequence; Blood Grouping and Crossmatching; methods; Exons; genetics; Genotype; Genotyping Techniques; methods; Heterozygote; Humans; Male; N-Acetylgalactosaminyltransferases; genetics; Phenotype; Point Mutation; Sequence Analysis, DNA; methods
- From: Chinese Journal of Medical Genetics 2015;32(6):837-839
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the molecular basis for a rare Ax13B phenotype of the ABO subtype.
METHODSSerological assays were carried out to characterize the erythrocyte phenotype of the discrepant sample. Exons 6 and 7 of the ABO gene were amplified with polymerase chain reaction and subjected to direct sequencing. The amplicons were also cloned to separate the two alleles.
RESULTSBoth A and B antigens were detected on the red blood cells of the proband, and anti-A antibody was detected in the serum. The serological phenotype of the sample was identified as AxB. DNA sequencing showed heterozygous status for 297AG, 526CG, 657CT, 703AG, 796AC, 803GC, 930GA and 940AG in exons 6 and 7. After cloning and sequencing, two alleles Ax13 and B101 were obtained. The sequence of Ax13 showed a nucleotide change (A to G) at position 940.
CONCLUSIONThe 940A>G mutation of the α-1,3-N-acetylgalactosaminyltransferase gene has resulted in the reduced expression of A antigen.